SynthesisInternational ophthalmology2025
Amniotic membrane transplantation for macular holes: decoding the optimal approach-inlay or overlay?
Synthesis in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNo consensus has been reached on the treatment of refractory/recurrent macular holes (MHs), chronic MHs, or highly myopic MHs. Although amniotic membrane transplantation (AMT) has been extended from ocular surface surgery to MH treatment, the comparative advantages of inlay versus overlay application of human amniotic membrane (hAM), as well as the impact of different preparation and preservation methods, remain controversial.
methodsA systematic review of recent literature on AMT for MHs was conducted, categorizing applications and summarizing critical surgical considerations.
resultsCurrent studies indicate: Inlay AMT is suitable for complex MHs, providing mechanical support, while overlay AMT promotes better healing. Preparation methods (e.g., freeze-dried vs. fresh amniotic membrane) may affect biological activity. Surgical approaches should be tailored based on MH type, disease duration, and individual patient factors.
conclusionAMT offers a novel approach to MH treatment, but standardized patient selection criteria and surgical techniques require further refinement. This review provides valuable insights for clinicians in optimizing surgical strategies.
Indexed as
Identifiers
41060538What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.